Table of Contents
February 1, 2023; Volume 64,Issue 2
Achilefu, Samuel
- Open AccessFirst-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET ImagingRichard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh DehdashtiJournal of Nuclear Medicine February 1, 2023, 64 (2) 320-328; DOI: https://doi.org/10.2967/jnumed.122.264349
Ait-mohand, Samia
- Open Access68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer PatientsSébastien Tremblay, Jean-François Beaudoin, Ophélie Bélissant Benesty, Samia Ait-Mohand, Véronique Dumulon-Perreault, Étienne Rousseau, Éric E. Turcotte and Brigitte GuérinJournal of Nuclear Medicine February 1, 2023, 64 (2) 232-238; DOI: https://doi.org/10.2967/jnumed.121.263768
Alavi, Abass
- You have accessNuclear Medicine: The EssentialsAbass AlaviJournal of Nuclear Medicine February 1, 2023, 64 (2) 341; DOI: https://doi.org/10.2967/jnumed.122.264788
Allen-auerbach, Martin
- You have accessSNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine TumorsThomas A. Hope, Martin Allen-Auerbach, Lisa Bodei, Jeremie Calais, Magnus Dahlbom, Lisa K. Dunnwald, Michael M. Graham, Heather A. Jacene, Courtney Lawhn Heath, Erik S. Mittra, Chadwick L. Wright, Wolfgang P. Fendler, Ken Herrmann, David Taïeb and Andreas KjaerJournal of Nuclear Medicine February 1, 2023, 64 (2) 204-210; DOI: https://doi.org/10.2967/jnumed.122.264860
Almaghrabi, Maan T.
- You have accessScientific Fraud, Publication Bias, and Honorary Authorship in Nuclear MedicineThomas C. Kwee, Maan T. Almaghrabi and Robert M. KweeJournal of Nuclear Medicine February 1, 2023, 64 (2) 200-203; DOI: https://doi.org/10.2967/jnumed.122.264679
Andreassen, Mikkel
- You have accessProspective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine NeoplasmsEsben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge and Andreas KjaerJournal of Nuclear Medicine February 1, 2023, 64 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.122.264383
Angoulvant, Denis
- Open AccessPrecision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver VariabilityMatthieu Bailly, Frédérique Thibault, Gilles Metrard, Maxime Courtehoux, Denis Angoulvant and Maria Joao RibeiroJournal of Nuclear Medicine February 1, 2023, 64 (2) 260-265; DOI: https://doi.org/10.2967/jnumed.122.264454
Antoch, Gerald
- You have accessClinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers and Julian KirchnerJournal of Nuclear Medicine February 1, 2023, 64 (2) 304-311; DOI: https://doi.org/10.2967/jnumed.122.264138
Ayers, Maria
- You have accessEvaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen and Louise EmmettJournal of Nuclear Medicine February 1, 2023, 64 (2) 221-226; DOI: https://doi.org/10.2967/jnumed.122.264398
Bahl, Amit
- Open AccessEligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate CancerGary J.R. Cook, Wai-Lup Wong, Bal Sanghera, Stephen Mangar, Amarnath Challapalli, Amit Bahl, Paul Bassett, Darren Leaning and Christian SchmidkonzJournal of Nuclear Medicine February 1, 2023, 64 (2) 227-231; DOI: https://doi.org/10.2967/jnumed.122.264296